Northwest Biotherapeutics raises $32M in a registered direct offering Northwest Biotherapeutics has entered into an agreement with a single institutional investor for a registered direct placement of up to $32M. The stock purchase agreement provides for the sale of an initial $15M of common stock at $6.60 per share. H.C. Wainwright & Co., LLC acted as the sole placement agent for the transaction.
Northwest Biotherapeutics raises $11.5M through an institutional stock sale Northwest Biotherapeutics announced that the Company has entered into an agreement with a single existing institutional shareholder for the purchase and sale of approximately $11.5M of newly issued shares of the Company's Common Stock at a price of $5.05 per share. H.C. Wainwright & Co., LLC acted as the sole placement agent for the transaction.